Analytical Data
-
Gene name
CNPY2
- Application
-
Alternative Names
ZSIG9; Cnpy2; MSAP; TMEM4; Transmembrane Protein 4; MIR-interacting saposin-like protein; Putative secreted protein Zsig9
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
Q9Y2B0
-
Expression Region
Arg21~Leu182
-
Molecular Weight
22kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CNPY2, a member of the CNPY (Cyanobacterial Osmostress Protein Y) family, has gained attention in recent years due to its emerging role in various biological processes and potential implications in human health. Originally identified in plants, CNPY proteins are believed to be involved in stress response mechanisms, particularly under osmotic stress conditions. However, research has expanded into mammalian systems, where CNPY2 has been implicated in cellular proliferation, differentiation, and maintaining homeostasis. Abnormal expression of CNPY2 has been linked to several pathological conditions, including cancer and metabolic disorders, prompting investigations into its functions at the molecular level. Structural studies of recombinant CNPY2 protein have aimed to elucidate its conformation and interactions with other cellular molecules, providing insights into its functional roles and potential therapeutic applications. As such, the exploration of CNPY2 as a recombinant protein not only enhances our understanding of its biological function but also underscores its potential as a target for innovative treatment strategies in diseases associated with dysregulated signaling pathways.
